Human mast cells decrease SLPI levels in type II-like alveolar cell model, in vitro

Cancer Cell International

Volumn 3, Issue , 2003, Pages

  Hollander, Camilla ^a   Nyström, Max ^a   Janciauskiene, Sabina ^a   Westin, Ulla ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Inflammation; Mast cells; Migration; SLPI

Indexed keywords

MESSENGER RNA; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ARTICLE; CELL INTERACTION; CELL LINE; CELL MIGRATION; CELL TYPE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME REGULATION; ENZYME RELEASE; ENZYME SYNTHESIS; EPITHELIUM CELL; EXPERIMENTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL; MAST CELL; MOLECULAR MODEL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; STATISTICAL SIGNIFICANCE;

EID: 2442706166     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-3-14     Document Type: Article

References (60)

1. Janoff A: Proteases and lung injury. A state-of-the-art minireview. Chest 1983, 83:54S-58S.
2. Janoff A: Elastase in tissue injury. Annu Rev Med 1985, 36:207-16.
3. Ohbayashi H: Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 2002, 3:409-21.
4. Tetley TD: Macrophages and the pathogenesis of COPD. Chest 2002, 121:156S-159S.
5. Finlay GA, Russell KJ, McMahon KJ, D'Arcy M, Masterson EJB, FitzGerald MX and O'Connor CM: Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997, 52:502-6.
6. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L and Boswell DR: Structure and variation of human alpha 1-antitrypsin. Nature 1982, 298:329-34.
7. Fryksmark U, Ohlsson K, Polling A and Tegner H: Distribution of antileukoprotease in upper respiratory mucosa. Ann Otol Rhinol Laryngol 1982, 91:268-71.
8. Mooren HW, Kramps JA, Franken C, Meijer CJ and Dijkman JA: Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung. Thorax 1983, 38:180-3.
9. Ohlsson M, Fryksmark U, Polling A, Tegner H and Ohlsson K: Localization of antileukoprotease in the parotid and the submandibular salivary glands. Acta Otolaryngol 1984, 98:147-51.
10. Kuijpers AL, Alkemade HA, Schalkwijk J and van de Kerkhof PC: Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis. Acta Derm Venereol 1995, 75:110-3.
11. Mihaila A and Tremblay GM: Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z Naturforsch [C] 2001, 56:291-7.
12. Saitoh H, Masuda T, Shimura S, Fushimi T and Shirato K: Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. Am J Physiol Lung Cell Mol Physiol 2001, 280:L79-87.
13. Ohlsson K and Tegner H: Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976, 36:437-45.
14. Ohlsson K, Bjartell A and Lilja H: Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. J Androl 1995, 16:64-74.
15. Tegner H: Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol 1978, 85:282-9.
16. Fritz H: Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol Chem Hoppe Seyler 1988, 369(Suppl):79-82.
17. Thompson RC and Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A 1986, 83:6692-6.
18. Hochstrasser K, Reichert R, Schwarz S and Werle E: [Isolation and characterisation of a protease inhibitor from human bronchial secretion]. Hoppe Seylers Z Physiol Chem 1972, 353:221-6.
19. Eisenberg SP, Hale KK, Heimdal P and Thompson RC: Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 1990, 265:7976-81.
20. Renesto P, Balloy V, Kamimura T, Masuda K, Imaizumi A and Chignard M: Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Br J Pharmacol 1993, 108:1100-6.
21. Masuda K, Kamimura T, Kanesaki M, Ishii K, Imaizumi A, Sugiyama T, Suzuki Y and Ohtsuka E: Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombincleavable fusion protein in Escherichia coli. Protein Eng 1996, 9:101-6.
22. Pemberton AD, Huntley JF and Miller HR: Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor. Biochim Biophys Acta 1998, 1379:29-34.
23. Shugars DC, Sauls DL and Weinberg JB: Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. Oral Dis 1997, 3(Suppl 1):S70-2.
24. Tomee JF, Koeter GH, Hiemstra PS and Kauffman HF: Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 1998, 53:114-6.
25. Jin FY, Nathan C, Radzioch D and Ding A: Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997, 88:417-26.
26. Jin F, Nathan CF, Radzioch D and Ding A: Lipopolysacchariderelated stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect Immun 1998, 66:2447-52.
27. Zang Y, De Witt DL, McNeely TB, Wahl SM and Wahl LM: Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteases. J Clin Invest 1997, 99:894-900.
28. Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V and Ward PA: Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 1999, 154:239-47.
29. Ward PA and Lentsch AB: Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 2002, 234-235:225-8.
30. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY and Wahl SM: Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000, 6:1147-53.
31. Bruch M and Bieth JG: Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 1986, 238:269-73.
32. Ohlsson K: Interactions between granulocyte proteases and protease inhibitors in the lung. Bull Eur Physiopathol Respir 1980, 16:209-22.
33. Abbinante-Nissen JM, Simpson LG and Leikauf GD: Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1993, 265:L286-92.
34. Sallenave JM, Shulmann J, Crossley J, Jordana M and Gauldie J: Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994, 11:733-41.
35. Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU and Ding A: Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med 2000, 28:1276-82.
36. Abbinante-Nissen JM, Simpson LG and Leikauf GD: Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995, 268:L601-6.
37. van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J and Hiemstra PS: Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 2000, 278:L51-8.
38. Ochnio JJ, Abboud RT, Lam S, Johal SS, Smith CJ and Johnson DA: Bronchial leukocyte proteinase inhibitor levels in bronchial washings in asthma patients. Chest 1988, 93:1008-12.
39. Westin U, Lundberg E, Wihl JA and Ohlsson K: The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge. Allergy 1999, 54:857-64.
40. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J and Chi DS: The human mast cell: functions in physiology and disease. Front Biosci 2001, 6:D1109-27.
41. Bradding P and Holgate ST: The mast cell as a source of cytokines in asthma. Ann N Y Acad Sci 1996, 796:272-81.
42. Bradding P and Holgate ST: Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999, 31:119-33.
43. Anderson DF, Zhang S, Bradding P, McGill JI, Holgate ST and Roche WR: The relative contribution of mast cell subsets to conjunctival TH2-like cytokines. Invest Ophthalmol Vis Sci 2001, 42:995-1001.
44. Church MK and Cauldfield JP: Mast cells and basophil functions. In: Allery Edited by: Holgate ST, Church MK. Gover Medical Publishing; 1993:5.1-5.12.
45. Dietze SC, Sommerhoff CP and Fritz H: Inhibition of histamine release from human mast cells ex vivo by natural and synthetic chymase inhibitors. Biol Chem Hoppe Seyler 1990, 371(Suppl):75-9.
46. Westin U, Lundberg E and Ohlsson K: IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release. Mediators Inflamm 1998, 7:217-20.
47. Westin U, Polling A, Ljungkrantz I and Ohlsson K: Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation. Biol Chem 1999, 380:489-93.
48. Hill AT, Bayley D and Stockley RA: The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999, 160:893-8.
49. Pierce JA, Jeppsson JO and Laurell CB: alpha-1 Antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serum. Anal Biochem 1976, 74:227-41.
50. Sigsgaard T, Brandslund L, Omland O, Hjort C, Lund ED, Pedersen OF and MR Miller: S and Z alpha1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/environment interaction. Eur Respir J 2000, 16:50-5.
51. Chaughey GH: The structure and airway biology of mast cell proteinases. Am J Resoir Cell Mol Biol 1991, 4:387-394.
52. Nilsson G and Metcalf DD: Contemporary issues in mast cell biology. Allergy and Asthma Proc 1990, 17:59-63.
53. Trautmann A, Feuerstein B, Ernst N, Brocker EB and Klein CE: Heterotypic cell-cell adhesion of human mast cells to fibroblasts. Arch Dermatol Res 1997, 289:194-203.
54. Kruger-Krasagakes S, Grutzkau A, Baghramian B and Henz BM: Interactions of immature human mast cells with extracellular matrix: expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol 1996, 106:538-43.
55. Weber S, Babina M, Feller G and Henz BM: Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. Scand J Immunol 1997, 45:471-81.
56. Olsson N, Piek E, ten Dijke P and Nilsson G: Human mast cell migration in response to members of the transforming growth factor-beta family. J Leukoc Biol 2000, 67:350-6.
57. Turner H and Kinet JP: Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999, 402:B24-30.
58. Miller HD and Pemberton AD: Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002, 04:375-390.
59. Butterfield JH, Weiler D, Dewald G and Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988, 12:345-355.
60. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-9.